Needham & Company LLC Predicts Reduced Earnings for Teleflex

Teleflex Incorporated (NYSE:TFX) – Stock analysts at Needham & Company LLC reduced their Q4 2025 earnings per share (EPS) estimates for shares of Teleflex in a report issued on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now forecasts that the medical technology company will post earnings per share of $3.65 for the quarter, down from their prior forecast of $3.80. Needham & Company LLC has a “Buy” rating and a $138.00 price target on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

TFX has been the subject of several other reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a research report on Wednesday, December 17th. Truist Financial upped their price objective on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Wells Fargo & Company cut their target price on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday. Finally, Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Teleflex has an average rating of “Hold” and an average target price of $139.00.

Teleflex Price Performance

TFX opened at $105.45 on Thursday. Teleflex has a 1 year low of $100.18 and a 1 year high of $184.58. The stock has a 50-day moving average price of $116.22 and a 200-day moving average price of $119.63. The firm has a market cap of $4.66 billion, a PE ratio of -14.35, a P/E/G ratio of 1.38 and a beta of 0.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The business had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. During the same period in the previous year, the company posted $3.49 earnings per share. The company’s revenue for the quarter was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. Teleflex’s dividend payout ratio is currently -18.50%.

Institutional Investors Weigh In On Teleflex

Large investors have recently made changes to their positions in the company. Russell Investments Group Ltd. increased its holdings in Teleflex by 23.6% in the 2nd quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock worth $9,870,000 after acquiring an additional 15,935 shares in the last quarter. Speece Thorson Capital Group Inc. lifted its holdings in Teleflex by 2.4% during the second quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock valued at $10,634,000 after purchasing an additional 2,096 shares in the last quarter. Creative Planning boosted its position in shares of Teleflex by 76.5% in the second quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock worth $1,224,000 after purchasing an additional 4,480 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in shares of Teleflex by 113.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock worth $7,366,000 after purchasing an additional 30,912 shares in the last quarter. Finally, CWM LLC raised its position in shares of Teleflex by 160.8% during the 2nd quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock valued at $1,409,000 after purchasing an additional 7,340 shares during the period. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.